03/01/2022 |
PROVOCHOLINE NDA #019193 |
SUPPL-26 |
METHACHOLINE CHLORIDE |
METHAPHARM |
Manufacturing (CMC) |
Approval |
03/01/2022 |
ULTANE NDA #020478 |
SUPPL-23 |
SEVOFLURANE |
ABBVIE |
Labeling |
Approval |
03/01/2022 |
ULTANE NDA #020478 |
SUPPL-24 |
SEVOFLURANE |
ABBVIE |
Labeling |
Approval |
03/01/2022 |
ULTANE NDA #020478 |
SUPPL-27 |
SEVOFLURANE |
ABBVIE |
Labeling |
Approval |
03/01/2022 |
ULTANE NDA #020478 |
SUPPL-28 |
SEVOFLURANE |
ABBVIE |
Labeling |
Approval |
03/01/2022 |
PREVACID 24 HR NDA #022327 |
SUPPL-29 |
LANSOPRAZOLE |
PERRIGO PHARMA INTL |
Labeling |
Approval |
03/01/2022 |
XARELTO NDA #022406 |
SUPPL-39 |
RIVAROXABAN |
JANSSEN PHARMS |
Labeling |
Approval |
03/01/2022 |
KURVELO ANDA #091408 |
SUPPL-13 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
LUPIN LTD |
Labeling |
Approval |
03/01/2022 |
XARELTO NDA #202439 |
SUPPL-38 |
RIVAROXABAN |
JANSSEN PHARMS |
Labeling |
Approval |
03/01/2022 |
ONDANSETRON HYDROCHLORIDE ANDA #202599 |
SUPPL-9 |
ONDANSETRON HYDROCHLORIDE |
EUGIA PHARMA |
Labeling |
Approval |
03/01/2022 |
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ANDA #202600 |
SUPPL-11 |
ONDANSETRON HYDROCHLORIDE |
EUGIA PHARMA |
Labeling |
Approval |
03/01/2022 |
MAYZENT NDA #209884 |
SUPPL-7 |
SIPONIMOD |
NOVARTIS |
Efficacy |
Approval |
03/01/2022 |
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE ANDA #212472 |
ORIG-1 |
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE |
ACTAVIS LABS FL INC |
|
Approval |
03/01/2022 |
LENVATINIB ANDA #213092 |
ORIG-1 |
LENVATINIB MESYLATE |
SUN PHARM INDS INC |
|
Tentative Approval |
03/02/2022 |
ALEVE-D SINUS & COLD NDA #021076 |
SUPPL-17 |
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE |
BAYER |
Labeling |
Approval |
03/02/2022 |
ORAQIX NDA #021451 |
SUPPL-13 |
LIDOCAINE; PRILOCAINE |
DENTSPLY PHARM |
Labeling |
Approval |
03/02/2022 |
VENTAVIS NDA #021779 |
SUPPL-21 |
ILOPROST |
ACTELION |
Labeling |
Approval |
03/02/2022 |
STEGLUJAN NDA #209805 |
SUPPL-10 |
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE |
MSD SUB MERCK |
Labeling |
Approval |
03/02/2022 |
SEGLUROMET NDA #209806 |
SUPPL-8 |
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE |
MSD SUB MERCK |
Labeling |
Approval |
03/02/2022 |
EFINACONAZOLE ANDA #212169 |
ORIG-1 |
EFINACONAZOLE |
LUPIN LTD |
|
Approval |
03/02/2022 |
SITAGLIPTIN ANDA #214054 |
ORIG-1 |
SITAGLIPTIN |
INTAS PHARMS USA |
|
Tentative Approval |
03/02/2022 |
ARFORMOTEROL TARTRATE ANDA #214736 |
ORIG-1 |
ARFORMOTEROL TARTRATE |
RITEDOSE CORP |
|
Approval |
03/03/2022 |
DILANTIN-125 NDA #008762 |
SUPPL-66 |
PHENYTOIN |
VIATRIS |
Labeling |
Approval |
03/03/2022 |
DILANTIN-30 NDA #008762 |
SUPPL-66 |
PHENYTOIN |
VIATRIS |
Labeling |
Approval |
03/03/2022 |
TAZICEF ANDA #064032 |
SUPPL-14 |
CEFTAZIDIME |
HOSPIRA |
Labeling |
Approval |
03/03/2022 |
TAZICEF ANDA #064032 |
SUPPL-16 |
CEFTAZIDIME |
HOSPIRA |
Labeling |
Approval |
03/03/2022 |
TAZICEF ANDA #064032 |
SUPPL-20 |
CEFTAZIDIME |
HOSPIRA |
Labeling |
Approval |
03/03/2022 |
TAZICEF ANDA #064032 |
SUPPL-25 |
CEFTAZIDIME |
HOSPIRA |
Labeling |
Approval |
03/03/2022 |
LARIN 24 FE ANDA #202994 |
SUPPL-2 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
NOVAST LABS |
Labeling |
Approval |
03/03/2022 |
LARIN 24 FE ANDA #202994 |
SUPPL-9 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
NOVAST LABS |
Labeling |
Approval |
03/03/2022 |
NIACIN ANDA #204934 |
ORIG-1 |
NIACIN |
MACLEODS PHARMS LTD |
|
Approval |
03/04/2022 |
OMNIPRED NDA #017469 |
SUPPL-47 |
PREDNISOLONE ACETATE |
SANDOZ |
Labeling |
Approval |
03/04/2022 |
NICODERM CQ NDA #020165 |
SUPPL-47 |
NICOTINE |
CHATTEM SANOFI |
Labeling |
Approval |
03/04/2022 |
PREVACID NDA #020406 |
SUPPL-94 |
LANSOPRAZOLE |
TAKEDA PHARMS USA |
Labeling |
Approval |
03/04/2022 |
ACIPHEX NDA #020973 |
SUPPL-42 |
RABEPRAZOLE SODIUM |
WAYLIS THERAP |
Labeling |
Approval |
03/04/2022 |
PROTONIX NDA #020987 |
SUPPL-58 |
PANTOPRAZOLE SODIUM |
WYETH PHARMS |
Labeling |
Approval |
03/04/2022 |
PROTONIX IV NDA #020988 |
SUPPL-64 |
PANTOPRAZOLE SODIUM |
WYETH PHARMS |
Labeling |
Approval |
03/04/2022 |
NEXIUM NDA #021153 |
SUPPL-59 |
ESOMEPRAZOLE MAGNESIUM |
ASTRAZENECA |
Labeling |
Approval |
03/04/2022 |
PREVACID NDA #021428 |
SUPPL-41 |
LANSOPRAZOLE |
TAKEDA PHARMS USA |
Labeling |
Approval |
03/04/2022 |
WELLBUTRIN XL NDA #021515 |
SUPPL-44 |
BUPROPION HYDROCHLORIDE |
BAUSCH |
Labeling |
Approval |
03/04/2022 |
ZEGERID NDA #021636 |
SUPPL-24 |
OMEPRAZOLE; SODIUM BICARBONATE |
SALIX |
Labeling |
Approval |
03/04/2022 |
NEXIUM IV NDA #021689 |
SUPPL-37 |
ESOMEPRAZOLE SODIUM |
ASTRAZENECA |
Labeling |
Approval |
03/04/2022 |
ZEGERID NDA #021849 |
SUPPL-19 |
OMEPRAZOLE; SODIUM BICARBONATE |
SALIX |
Labeling |
Approval |
03/04/2022 |
NEXIUM NDA #021957 |
SUPPL-26 |
ESOMEPRAZOLE MAGNESIUM |
ASTRAZENECA |
Labeling |
Approval |
03/04/2022 |
PROTONIX NDA #022020 |
SUPPL-21 |
PANTOPRAZOLE SODIUM |
WYETH PHARMS |
Labeling |
Approval |
03/04/2022 |
PRILOSEC NDA #022056 |
SUPPL-25 |
OMEPRAZOLE MAGNESIUM |
COVIS |
Labeling |
Approval |
03/04/2022 |
NEXIUM NDA #022101 |
SUPPL-23 |
ESOMEPRAZOLE MAGNESIUM |
ASTRAZENECA |
Labeling |
Approval |
03/04/2022 |
APLENZIN NDA #022108 |
SUPPL-22 |
BUPROPION HYDROBROMIDE |
BAUSCH |
Labeling |
Approval |
03/04/2022 |
DEXILANT NDA #022287 |
SUPPL-35 |
DEXLANSOPRAZOLE |
TAKEDA PHARMS USA |
Labeling |
Approval |
03/04/2022 |
VIMOVO NDA #022511 |
SUPPL-28 |
ESOMEPRAZOLE MAGNESIUM; NAPROXEN |
HORIZON |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN NDA #050824 |
SUPPL-10 |
AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE |
CUMBERLAND |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #075347 |
SUPPL-29 |
OMEPRAZOLE |
ACTAVIS LABS FL INC |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #075410 |
SUPPL-66 |
OMEPRAZOLE |
LANNETT CO INC |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #075576 |
SUPPL-22 |
OMEPRAZOLE |
DR REDDYS LABS LTD |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #075757 |
SUPPL-54 |
OMEPRAZOLE |
SANDOZ |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #075785 |
SUPPL-12 |
OMEPRAZOLE |
IMPAX LABS |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #075876 |
SUPPL-44 |
OMEPRAZOLE |
STRIDES PHARMA |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #076048 |
SUPPL-28 |
OMEPRAZOLE |
APOTEX |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #076515 |
SUPPL-35 |
OMEPRAZOLE |
SANDOZ |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #078490 |
SUPPL-18 |
OMEPRAZOLE |
DR REDDYS LABS LTD |
Labeling |
Approval |
03/04/2022 |
ALTAVERA ANDA #079102 |
SUPPL-10 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
XIROMED |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #091352 |
SUPPL-21 |
OMEPRAZOLE |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
03/04/2022 |
LEVONORGESTREL AND ETHINYL ESTRADIOL ANDA #091663 |
SUPPL-8 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
XIROMED |
Labeling |
Approval |
03/04/2022 |
LEVONORGESTREL AND ETHINYL ESTRADIOL ANDA #091663 |
SUPPL-11 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
XIROMED |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #091672 |
SUPPL-22 |
OMEPRAZOLE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
03/04/2022 |
OPDIVO BLA #125554 |
SUPPL-112 |
NIVOLUMAB |
BRISTOL MYERS SQUIBB |
|
Approval |
03/04/2022 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #200218 |
SUPPL-6 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
ANI PHARMS |
Labeling |
Approval |
03/04/2022 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #200218 |
SUPPL-7 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
ANI PHARMS |
Labeling |
Approval |
03/04/2022 |
ESOMEPRAZOLE STRONTIUM NDA #202342 |
SUPPL-7 |
ESOMEPRAZOLE STRONTIUM |
BELCHER |
Labeling |
Approval |
03/04/2022 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #202588 |
SUPPL-1 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
SANDOZ |
Labeling |
Approval |
03/04/2022 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #202588 |
SUPPL-4 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
SANDOZ |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #203270 |
SUPPL-19 |
OMEPRAZOLE |
AUROBINDO PHARMA |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #203481 |
SUPPL-6 |
OMEPRAZOLE |
BRECKENRIDGE |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #204012 |
SUPPL-2 |
OMEPRAZOLE |
HETERO LABS LTD III |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #204661 |
SUPPL-7 |
OMEPRAZOLE |
TEVA PHARMS USA |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #205070 |
SUPPL-3 |
OMEPRAZOLE |
MYLAN |
Labeling |
Approval |
03/04/2022 |
YOSPRALA NDA #205103 |
SUPPL-8 |
ASPIRIN; OMEPRAZOLE |
GENUS LIFESCIENCES |
Labeling |
Approval |
03/04/2022 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #206006 |
SUPPL-2 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
RISING |
Labeling |
Approval |
03/04/2022 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #206006 |
SUPPL-3 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
RISING |
Labeling |
Approval |
03/04/2022 |
QTERN NDA #209091 |
SUPPL-6 |
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE |
ASTRAZENECA AB |
Labeling |
Approval |
03/04/2022 |
PANTOPRAZOLE SODIUM NDA #209463 |
SUPPL-15 |
PANTOPRAZOLE SODIUM |
HIKMA |
Labeling |
Approval |
03/04/2022 |
OMEPRAZOLE ANDA #212977 |
SUPPL-4 |
OMEPRAZOLE |
XIROMED |
Labeling |
Approval |
03/04/2022 |
TALICIA NDA #213004 |
SUPPL-7 |
AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN |
REDHILL |
Labeling |
Approval |
03/04/2022 |
PALBOCICLIB ANDA #213152 |
ORIG-1 |
PALBOCICLIB |
AIZANT DRUG RESEARCH SOLUTIONS PVT LTD |
|
Tentative Approval |
03/04/2022 |
NYSTATIN AND TRIAMCINOLONE ACETONIDE ANDA #214186 |
ORIG-1 |
NYSTATIN; TRIAMCINOLONE ACETONIDE |
ALEMBIC |
|
Approval |
03/04/2022 |
PRADAXA NDA #214358 |
SUPPL-2 |
DABIGATRAN ETEXILATE MESYLATE |
BOEHRINGER INGELHEIM |
Manufacturing (CMC) |
Approval |
03/04/2022 |
DICLOFENAC POTASSIUM ANDA #215375 |
ORIG-1 |
DICLOFENAC POTASSIUM |
ANNORA PHARMA |
|
Approval |
03/04/2022 |
DARZALEX BLA #761036 |
SUPPL-41 |
DARATUMUMAB |
JANSSEN BIOTECH |
|
Approval |
03/04/2022 |
AIMOVIG BLA #761077 |
SUPPL-14 |
ERENUMAB-AOOE |
AMGEN INC |
|
Approval |
03/07/2022 |
ZOCOR NDA #019766 |
SUPPL-99 |
SIMVASTATIN |
ORGANON |
Labeling |
Approval |
03/07/2022 |
LEVORA 0.15/30-28 ANDA #073594 |
SUPPL-28 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
DR REDDYS LABS SA |
Labeling |
Approval |
03/07/2022 |
LEVORA 0.15/30-28 ANDA #073594 |
SUPPL-30 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
DR REDDYS LABS SA |
Labeling |
Approval |
03/07/2022 |
ALLOPURINOL ANDA #214443 |
ORIG-1 |
ALLOPURINOL |
HARMAN FINOCHEM |
|
Approval |
03/08/2022 |
LUMIGAN NDA #021275 |
SUPPL-29 |
BIMATOPROST |
ABBVIE |
Labeling |
Approval |
03/08/2022 |
LUMIGAN NDA #022184 |
SUPPL-9 |
BIMATOPROST |
ABBVIE |
Labeling |
Approval |
03/08/2022 |
QSYMIA NDA #022580 |
SUPPL-20 |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
VIVUS LLC |
REMS |
Approval |
03/08/2022 |
HYDROXYCHLOROQUINE SULFATE ANDA #040081 |
SUPPL-32 |
HYDROXYCHLOROQUINE SULFATE |
TEVA PHARMS |
Labeling |
Approval |
03/08/2022 |
MYCOPHENOLATE MOFETIL ANDA #065379 |
SUPPL-32 |
MYCOPHENOLATE MOFETIL |
SANDOZ |
Labeling |
Approval |
03/08/2022 |
MYCOPHENOLATE MOFETIL ANDA #065451 |
SUPPL-32 |
MYCOPHENOLATE MOFETIL |
SANDOZ |
Labeling |
Approval |
03/08/2022 |
MYCOPHENOLATE MOFETIL ANDA #065520 |
SUPPL-32 |
MYCOPHENOLATE MOFETIL |
MYLAN |
Labeling |
Approval |
03/08/2022 |
MYCOPHENOLATE MOFETIL ANDA #065521 |
SUPPL-30 |
MYCOPHENOLATE MOFETIL |
MYLAN |
Labeling |
Approval |
03/08/2022 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH ANDA #070030 |
SUPPL-40 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
HERITAGE PHARMA AVET |
Labeling |
Approval |
03/08/2022 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH ANDA #070030 |
SUPPL-41 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
HERITAGE PHARMA AVET |
Labeling |
Approval |
03/08/2022 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH ANDA #070037 |
SUPPL-39 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
HERITAGE PHARMA AVET |
Labeling |
Approval |
03/08/2022 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH ANDA #070037 |
SUPPL-40 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
HERITAGE PHARMA AVET |
Labeling |
Approval |
03/08/2022 |
OXALIPLATIN ANDA #091358 |
SUPPL-9 |
OXALIPLATIN |
MYLAN LABS LTD |
Labeling |
Approval |
03/08/2022 |
LETROZOLE ANDA #201804 |
SUPPL-2 |
LETROZOLE |
INDICUS PHARMA |
Labeling |
Approval |
03/08/2022 |
MYCOPHENOLATE MOFETIL ANDA #203005 |
SUPPL-10 |
MYCOPHENOLATE MOFETIL |
ALKEM LABS LTD |
Labeling |
Approval |
03/08/2022 |
LEVETIRACETAM ANDA #203308 |
SUPPL-8 |
LEVETIRACETAM |
MYLAN LABS LTD |
Labeling |
Approval |
03/08/2022 |
DUTASTERIDE ANDA #204292 |
SUPPL-3 |
DUTASTERIDE |
APOTEX |
Labeling |
Approval |
03/08/2022 |
NITROGLYCERIN ANDA #210153 |
ORIG-1 |
NITROGLYCERIN |
ZYDUS PHARMS |
|
Approval |
03/08/2022 |
PREGABALIN ANDA #212988 |
ORIG-1 |
PREGABALIN |
ESKAYEF |
|
Approval |
03/09/2022 |
DIFLUCAN NDA #019949 |
SUPPL-71 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
03/09/2022 |
DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER NDA #019950 |
SUPPL-70 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
03/09/2022 |
DIFLUCAN IN SODIUM CHLORIDE 0.9% NDA #019950 |
SUPPL-70 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
03/09/2022 |
DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER NDA #019950 |
SUPPL-70 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
03/09/2022 |
DIFLUCAN NDA #020090 |
SUPPL-52 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
03/09/2022 |
MYOVIEW NDA #020372 |
SUPPL-31 |
TECHNETIUM TC-99M TETROFOSMIN KIT |
GE HEALTHCARE |
Labeling |
Approval |
03/09/2022 |
MYOVIEW 30ML NDA #020372 |
SUPPL-31 |
TECHNETIUM TC-99M TETROFOSMIN KIT |
GE HEALTHCARE |
Labeling |
Approval |
03/09/2022 |
LEVORA 0.15/30-21 ANDA #073592 |
SUPPL-21 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
WATSON LABS |
Labeling |
Approval |
03/09/2022 |
PORTIA-21 ANDA #075866 |
SUPPL-31 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
BARR |
Labeling |
Approval |
03/09/2022 |
PORTIA-28 ANDA #075866 |
SUPPL-31 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
BARR |
Labeling |
Approval |
03/09/2022 |
CELECOXIB ANDA #078857 |
SUPPL-13 |
CELECOXIB |
MYLAN |
Labeling |
Approval |
03/09/2022 |
CELECOXIB ANDA #204776 |
SUPPL-10 |
CELECOXIB |
MICRO LABS |
Labeling |
Approval |
03/09/2022 |
CELECOXIB ANDA #207446 |
SUPPL-11 |
CELECOXIB |
CIPLA |
Labeling |
Approval |
03/09/2022 |
CLOBAZAM ANDA #211032 |
SUPPL-1 |
CLOBAZAM |
TEVA PHARMS USA |
Labeling |
Approval |
03/09/2022 |
BEOVU BLA #761125 |
SUPPL-2 |
brolucizumab-dbll |
NOVARTIS PHARMS CORP |
|
Approval |
03/10/2022 |
ALEVE NDA #020204 |
SUPPL-83 |
NAPROXEN SODIUM |
BAYER |
Labeling |
Approval |
03/10/2022 |
ERYTHROMYCIN ANDA #062746 |
SUPPL-12 |
ERYTHROMYCIN |
AZURITY |
Labeling |
Approval |
03/10/2022 |
ERYTHROMYCIN ANDA #062746 |
SUPPL-14 |
ERYTHROMYCIN |
AZURITY |
Labeling |
Approval |
03/10/2022 |
CLOTRIMAZOLE ANDA #074165 |
SUPPL-43 |
CLOTRIMAZOLE |
P AND L |
Labeling |
Approval |
03/10/2022 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #200218 |
SUPPL-9 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
ANI PHARMS |
Labeling |
Approval |
03/10/2022 |
RUFINAMIDE ANDA #205075 |
SUPPL-1 |
RUFINAMIDE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
03/10/2022 |
RUFINAMIDE ANDA #205095 |
SUPPL-2 |
RUFINAMIDE |
MYLAN |
Labeling |
Approval |
03/10/2022 |
ZYDELIG NDA #205858 |
SUPPL-17 |
IDELALISIB |
GILEAD SCIENCES INC |
REMS |
Approval |
03/10/2022 |
ENTERO VU 24% NDA #208143 |
SUPPL-13 |
BARIUM SULFATE |
BRACCO |
Manufacturing (CMC) |
Approval |
03/10/2022 |
LIQUID E-Z-PAQUE NDA #208143 |
SUPPL-13 |
BARIUM SULFATE |
BRACCO |
Manufacturing (CMC) |
Approval |
03/10/2022 |
READI-CAT 2 NDA #208143 |
SUPPL-13 |
BARIUM SULFATE |
BRACCO |
Manufacturing (CMC) |
Approval |
03/10/2022 |
READI-CAT 2 SMOOTHIE NDA #208143 |
SUPPL-13 |
BARIUM SULFATE |
BRACCO |
Manufacturing (CMC) |
Approval |
03/10/2022 |
TAGITOL V NDA #208143 |
SUPPL-13 |
BARIUM SULFATE |
BRACCO |
Manufacturing (CMC) |
Approval |
03/10/2022 |
VARIBAR HONEY NDA #208143 |
SUPPL-13 |
BARIUM SULFATE |
BRACCO |
Manufacturing (CMC) |
Approval |
03/10/2022 |
VARIBAR NECTAR NDA #208143 |
SUPPL-13 |
BARIUM SULFATE |
BRACCO |
Manufacturing (CMC) |
Approval |
03/10/2022 |
VARIBAR THIN HONEY NDA #208143 |
SUPPL-13 |
BARIUM SULFATE |
BRACCO |
Manufacturing (CMC) |
Approval |
03/10/2022 |
COLCHICINE ANDA #209173 |
ORIG-1 |
COLCHICINE |
STRIDES PHARMA |
|
Approval |
03/10/2022 |
BUSULFAN ANDA #210148 |
SUPPL-2 |
BUSULFAN |
ACCORD HLTHCARE INC |
Labeling |
Approval |
03/10/2022 |
VIGABATRIN ANDA #211790 |
ORIG-1 |
VIGABATRIN |
CHARTWELL RX |
|
Approval |
03/10/2022 |
METHOTREXATE NDA #214121 |
SUPPL-1 |
METHOTREXATE |
ACCORD HLTHCARE |
Efficacy |
Approval |
03/10/2022 |
NYSTATIN ANDA #214346 |
ORIG-1 |
NYSTATIN |
LEADING |
|
Approval |
03/10/2022 |
COLESTIPOL HYDROCHLORIDE ANDA #215223 |
ORIG-1 |
COLESTIPOL HYDROCHLORIDE |
ZYDUS PHARMS |
|
Approval |
03/11/2022 |
RISPERDAL NDA #020588 |
SUPPL-73 |
RISPERIDONE |
JANSSEN PHARMS |
Labeling |
Approval |
03/11/2022 |
NESINA NDA #022271 |
SUPPL-13 |
ALOGLIPTIN BENZOATE |
TAKEDA PHARMS USA |
Labeling |
Approval |
03/11/2022 |
OSENI NDA #022426 |
SUPPL-14 |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
TAKEDA PHARMS USA |
Labeling |
Approval |
03/11/2022 |
NAPROXEN ANDA #074140 |
SUPPL-37 |
NAPROXEN |
GRANULES |
Labeling |
Approval |
03/11/2022 |
NAPROXEN ANDA #074140 |
SUPPL-38 |
NAPROXEN |
GRANULES |
Labeling |
Approval |
03/11/2022 |
NAPROXEN ANDA #074140 |
SUPPL-40 |
NAPROXEN |
GRANULES |
Labeling |
Approval |
03/11/2022 |
NAPROXEN ANDA #074140 |
SUPPL-41 |
NAPROXEN |
GRANULES |
Labeling |
Approval |
03/11/2022 |
NAPROXEN ANDA #074140 |
SUPPL-42 |
NAPROXEN |
GRANULES |
Manufacturing (CMC) |
Approval |
03/11/2022 |
ONDANSETRON HYDROCHLORIDE ANDA #079224 |
SUPPL-18 |
ONDANSETRON HYDROCHLORIDE |
GLAND PHARMA LTD |
Labeling |
Approval |
03/11/2022 |
FINASTERIDE ANDA #090061 |
SUPPL-17 |
FINASTERIDE |
HETERO LABS LTD III |
Labeling |
Approval |
03/11/2022 |
FINASTERIDE ANDA #090061 |
SUPPL-18 |
FINASTERIDE |
HETERO LABS LTD III |
Labeling |
Approval |
03/11/2022 |
ONDANSETRON HYDROCHLORIDE ANDA #090648 |
SUPPL-14 |
ONDANSETRON HYDROCHLORIDE |
GLAND PHARMA LTD |
Labeling |
Approval |
03/11/2022 |
KAZANO NDA #203414 |
SUPPL-13 |
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE |
TAKEDA PHARMS USA |
Labeling |
Approval |
03/11/2022 |
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE ANDA #206180 |
SUPPL-8 |
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN |
AUROBINDO PHARMA |
Labeling |
Approval |
03/11/2022 |
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE ANDA #206180 |
SUPPL-9 |
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN |
AUROBINDO PHARMA |
Labeling |
Approval |
03/11/2022 |
FINASTERIDE ANDA #207750 |
SUPPL-1 |
FINASTERIDE |
ALKEM LABS LTD |
Labeling |
Approval |
03/11/2022 |
FINASTERIDE ANDA #207750 |
SUPPL-6 |
FINASTERIDE |
ALKEM LABS LTD |
Labeling |
Approval |
03/11/2022 |
LYNPARZA NDA #208558 |
SUPPL-23 |
OLAPARIB |
ASTRAZENECA |
Efficacy |
Approval |
03/11/2022 |
MACITENTAN ANDA #211128 |
ORIG-1 |
MACITENTAN |
ALEMBIC PHARMS LTD |
|
Tentative Approval |
03/11/2022 |
DAYVIGO NDA #212028 |
SUPPL-6 |
LEMBOREXANT |
EISAI INC |
Labeling |
Approval |
03/11/2022 |
ADLARITY NDA #212304 |
ORIG-1 |
DONEPEZIL HYDROCHLORIDE |
CORIUM |
Type 3 - New Dosage Form |
Approval |
03/11/2022 |
CISATRACURIUM BESYLATE ANDA #212432 |
ORIG-1 |
CISATRACURIUM BESYLATE |
PIRAMAL HLTHCARE UK |
|
Approval |
03/11/2022 |
DIGOXIN ANDA #215209 |
ORIG-1 |
DIGOXIN |
AMICI |
|
Approval |
03/14/2022 |
STROMECTOL NDA #050742 |
SUPPL-30 |
IVERMECTIN |
MERCK SHARP DOHME |
Labeling |
Approval |
03/14/2022 |
METHYLPHENIDATE ANDA #206497 |
ORIG-1 |
METHYLPHENIDATE |
MYLAN TECH VIATRIS |
|
Approval |
03/14/2022 |
AMLODIPINE BESYLATE AND VALSARTAN ANDA #206512 |
SUPPL-4 |
AMLODIPINE BESYLATE; VALSARTAN |
AUROBINDO PHARMA |
Labeling |
Approval |
03/14/2022 |
AMLODIPINE BESYLATE AND VALSARTAN ANDA #206512 |
SUPPL-7 |
AMLODIPINE BESYLATE; VALSARTAN |
AUROBINDO PHARMA |
Labeling |
Approval |
03/14/2022 |
CINVANTI NDA #209296 |
SUPPL-8 |
APREPITANT |
HERON THERAPS INC |
Manufacturing (CMC) |
Approval |
03/14/2022 |
DOXEPIN HYDROCHLORIDE ANDA #215483 |
ORIG-1 |
DOXEPIN HYDROCHLORIDE |
JUBILANT CADISTA |
|
Approval |
03/15/2022 |
MYFORTIC NDA #050791 |
SUPPL-35 |
MYCOPHENOLIC SODIUM |
NOVARTIS |
Labeling |
Approval |
03/15/2022 |
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ANDA #077343 |
SUPPL-11 |
ONDANSETRON HYDROCHLORIDE |
APOTEX INC |
Labeling |
Approval |
03/15/2022 |
ONDANSETRON HYDROCHLORIDE ANDA #077368 |
SUPPL-10 |
ONDANSETRON HYDROCHLORIDE |
APOTEX INC |
Labeling |
Approval |
03/15/2022 |
ONDANSETRON HYDROCHLORIDE ANDA #077473 |
SUPPL-14 |
ONDANSETRON HYDROCHLORIDE |
HOSPIRA |
Labeling |
Approval |
03/15/2022 |
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ANDA #077548 |
SUPPL-15 |
ONDANSETRON HYDROCHLORIDE |
HOSPIRA |
Labeling |
Approval |
03/15/2022 |
GALANTAMINE HYDROBROMIDE ANDA #090178 |
SUPPL-11 |
GALANTAMINE HYDROBROMIDE |
SUN PHARM |
Labeling |
Approval |
03/15/2022 |
GALANTAMINE HYDROBROMIDE ANDA #090178 |
SUPPL-13 |
GALANTAMINE HYDROBROMIDE |
SUN PHARM |
Labeling |
Approval |
03/15/2022 |
MARQIBO KIT NDA #202497 |
SUPPL-13 |
VINCRISTINE SULFATE |
ACROTECH |
Labeling |
Approval |
03/15/2022 |
IBRUTINIB ANDA #211267 |
ORIG-1 |
IBRUTINIB |
SANDOZ INC |
|
Tentative Approval |
03/15/2022 |
BREYNA ANDA #211699 |
ORIG-1 |
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE |
MYLAN |
|
Approval |
03/15/2022 |
SUCRALFATE ANDA #211884 |
ORIG-1 |
SUCRALFATE |
VISTAPHARM LLC |
|
Approval |
03/15/2022 |
DOXAZOSIN MESYLATE ANDA #212727 |
ORIG-1 |
DOXAZOSIN MESYLATE |
RISING |
|
Approval |
03/15/2022 |
ATROPINE SULFATE NDA #213581 |
ORIG-1 |
ATROPINE SULFATE |
BAUSCH AND LOMB INC |
Type 5 - New Formulation or New Manufacturer |
Approval |
03/15/2022 |
NEBIVOLOL HYDROCHLORIDE ANDA #213830 |
ORIG-1 |
NEBIVOLOL HYDROCHLORIDE |
UNICHEM |
|
Approval |
03/15/2022 |
GUAIFENESIN ANDA #215932 |
ORIG-1 |
GUAIFENESIN |
DR REDDYS |
|
Approval |
03/16/2022 |
REBETOL NDA #020903 |
SUPPL-57 |
RIBAVIRIN |
MERCK SHARP DOHME |
Labeling |
Approval |
03/16/2022 |
FERRLECIT NDA #020955 |
SUPPL-20 |
FERRIC OXYHYDROXIDE |
SANOFI AVENTIS US |
Labeling |
Approval |
03/16/2022 |
REBETOL NDA #021546 |
SUPPL-13 |
RIBAVIRIN |
SCHERING |
Labeling |
Approval |
03/16/2022 |
METROGEL NDA #021789 |
SUPPL-9 |
METRONIDAZOLE |
GALDERMA LABS LP |
Labeling |
Approval |
03/16/2022 |
METROGEL NDA #021789 |
SUPPL-10 |
METRONIDAZOLE |
GALDERMA LABS LP |
Labeling |
Approval |
03/16/2022 |
CHLOROQUINE PHOSPHATE ANDA #040516 |
SUPPL-13 |
CHLOROQUINE PHOSPHATE |
IMPAX LABS |
Labeling |
Approval |
03/16/2022 |
METHADONE HYDROCHLORIDE ANDA #040517 |
SUPPL-23 |
METHADONE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
03/16/2022 |
METHADONE HYDROCHLORIDE ANDA #040517 |
SUPPL-24 |
METHADONE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
03/16/2022 |
METHADONE HYDROCHLORIDE ANDA #040517 |
SUPPL-26 |
METHADONE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
03/16/2022 |
METHADONE HYDROCHLORIDE ANDA #040517 |
SUPPL-28 |
METHADONE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
03/16/2022 |
SANDIMMUNE NDA #050625 |
SUPPL-60 |
CYCLOSPORINE |
NOVARTIS |
Manufacturing (CMC) |
Approval |
03/16/2022 |
CYCLAFEM 1/35 ANDA #076337 |
SUPPL-9 |
ETHINYL ESTRADIOL; NORETHINDRONE |
ENDO OPERATIONS |
Labeling |
Approval |
03/16/2022 |
CYCLAFEM 1/35 ANDA #076337 |
SUPPL-10 |
ETHINYL ESTRADIOL; NORETHINDRONE |
ENDO OPERATIONS |
Labeling |
Approval |
03/16/2022 |
SUCCINYLCHOLINE CHLORIDE ANDA #211346 |
SUPPL-1 |
SUCCINYLCHOLINE CHLORIDE |
FRESENIUS KABI USA |
Labeling |
Approval |
03/16/2022 |
SPY AGENT GREEN KIT NDA #211580 |
SUPPL-4 |
INDOCYANINE GREEN |
NOVADAQ TECH |
Manufacturing (CMC) |
Approval |
03/16/2022 |
RINVOQ NDA #211675 |
SUPPL-7 |
UPADACITINIB |
ABBVIE |
Efficacy |
Approval |
03/17/2022 |
IC-GREEN NDA #011525 |
SUPPL-36 |
INDOCYANINE GREEN |
RENEW PHARMS |
Labeling |
Approval |
03/17/2022 |
INVANZ NDA #021337 |
SUPPL-51 |
ERTAPENEM SODIUM |
MSD SUB MERCK |
Labeling |
Approval |
03/17/2022 |
EMOQUETTE ANDA #076675 |
SUPPL-12 |
DESOGESTREL; ETHINYL ESTRADIOL |
ENDO OPERATIONS |
Labeling |
Approval |
03/17/2022 |
CHLOROQUINE PHOSPHATE ANDA #080880 |
SUPPL-65 |
CHLOROQUINE PHOSPHATE |
IMPAX LABS |
Labeling |
Approval |
03/17/2022 |
CHLOROQUINE PHOSPHATE ANDA #083082 |
SUPPL-57 |
CHLOROQUINE PHOSPHATE |
HIKMA PHARMS |
Labeling |
Approval |
03/17/2022 |
CHLOROQUINE PHOSPHATE ANDA #090249 |
SUPPL-6 |
CHLOROQUINE PHOSPHATE |
IPCA LABS LTD |
Labeling |
Approval |
03/17/2022 |
CHLOROQUINE PHOSPHATE ANDA #090610 |
SUPPL-8 |
CHLOROQUINE PHOSPHATE |
IPCA LABS LTD |
Labeling |
Approval |
03/17/2022 |
CHLOROQUINE PHOSPHATE ANDA #090612 |
SUPPL-3 |
CHLOROQUINE PHOSPHATE |
NATCO PHARMA LTD |
Labeling |
Approval |
03/17/2022 |
CHLOROQUINE PHOSPHATE ANDA #090612 |
SUPPL-4 |
CHLOROQUINE PHOSPHATE |
NATCO PHARMA LTD |
Labeling |
Approval |
03/17/2022 |
LACOSAMIDE ANDA #204787 |
ORIG-1 |
LACOSAMIDE |
HETERO LABS LTD V |
|
Approval |
03/17/2022 |
LACOSAMIDE ANDA #204857 |
ORIG-1 |
LACOSAMIDE |
AMNEAL PHARMS |
|
Approval |
03/17/2022 |
GALANTAMINE HYDROBROMIDE ANDA #204895 |
SUPPL-5 |
GALANTAMINE HYDROBROMIDE |
AUROBINDO PHARMA |
Labeling |
Approval |
03/17/2022 |
GALANTAMINE HYDROBROMIDE ANDA #204895 |
SUPPL-6 |
GALANTAMINE HYDROBROMIDE |
AUROBINDO PHARMA |
Labeling |
Approval |
03/17/2022 |
GALANTAMINE HYDROBROMIDE ANDA #204895 |
SUPPL-7 |
GALANTAMINE HYDROBROMIDE |
AUROBINDO PHARMA |
Labeling |
Approval |
03/17/2022 |
LACOSAMIDE ANDA #204921 |
ORIG-1 |
LACOSAMIDE |
MSN LABS PVT LTD |
|
Approval |
03/17/2022 |
LACOSAMIDE ANDA #204974 |
ORIG-1 |
LACOSAMIDE |
ALEMBIC |
|
Approval |
03/17/2022 |
LACOSAMIDE ANDA #205006 |
ORIG-1 |
LACOSAMIDE |
GLENMARK PHARMS LTD |
|
Approval |
03/17/2022 |
LACOSAMIDE ANDA #205031 |
ORIG-1 |
LACOSAMIDE |
SUN PHARM |
|
Approval |
03/17/2022 |
LACOSAMIDE ANDA #205237 |
ORIG-1 |
LACOSAMIDE |
SCIEGEN PHARMS INC |
|
Approval |
03/17/2022 |
PENTAMIDINE ISETHIONATE ANDA #206982 |
ORIG-1 |
PENTAMIDINE ISETHIONATE |
XGEN PHARMS |
|
Approval |
03/17/2022 |
LACOSAMIDE ANDA #208308 |
ORIG-1 |
LACOSAMIDE |
INDOCO |
|
Approval |
03/17/2022 |
CHLOROQUINE PHOSPHATE ANDA #214756 |
SUPPL-1 |
CHLOROQUINE PHOSPHATE |
SUVEN PHARMS |
Labeling |
Approval |
03/17/2022 |
SUCCINYLCHOLINE CHLORIDE NDA #215143 |
SUPPL-1 |
SUCCINYLCHOLINE CHLORIDE |
HIKMA |
Labeling |
Approval |
03/17/2022 |
NASONEX 24HR ALLERGY NDA #215712 |
ORIG-1 |
MOMETASONE FUROATE |
PERRIGO PHARMA INTL |
Type 8 - Partial Rx to OTC Switch |
Approval |
03/17/2022 |
VERAPAMIL HYDROCHLORIDE ANDA #215829 |
ORIG-1 |
VERAPAMIL HYDROCHLORIDE |
ACIC PHARMS |
|
Approval |
03/18/2022 |
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER NDA #050821 |
SUPPL-6 |
CEFEPIME HYDROCHLORIDE |
B BRAUN |
Labeling |
Approval |
03/18/2022 |
LEVONORGESTREL AND ETHINYL ESTRADIOL ANDA #202791 |
SUPPL-4 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
GLENMARK PHARMS LTD |
Labeling |
Approval |
03/18/2022 |
CHABELINA FE ANDA #202962 |
SUPPL-4 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
NOVAST LABS |
Labeling |
Approval |
03/18/2022 |
BROMFENAC SODIUM ANDA #204813 |
ORIG-1 |
BROMFENAC SODIUM |
EUGIA PHARMA |
|
Approval |
03/18/2022 |
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL ANDA #205069 |
SUPPL-2 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
XIROMED |
Labeling |
Approval |
03/18/2022 |
ATROPINE SULFATE NDA #206289 |
SUPPL-11 |
ATROPINE SULFATE |
RISING |
Labeling |
Approval |
03/18/2022 |
LABETALOL HYDROCHLORIDE NDA #213330 |
SUPPL-3 |
LABETALOL HYDROCHLORIDE |
HIKMA |
Manufacturing (CMC) |
Approval |
03/18/2022 |
LABETALOL HYDROCHLORIDE IN DEXTROSE NDA #213330 |
SUPPL-3 |
LABETALOL HYDROCHLORIDE |
HIKMA |
Manufacturing (CMC) |
Approval |
03/18/2022 |
LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE NDA #213330 |
SUPPL-3 |
LABETALOL HYDROCHLORIDE |
HIKMA |
Manufacturing (CMC) |
Approval |
03/18/2022 |
WINLEVI NDA #213433 |
SUPPL-2 |
CLASCOTERONE |
SUN PHARM |
Labeling |
Approval |
03/18/2022 |
ZTALMY NDA #215904 |
ORIG-1 |
GANAXOLONE |
MARINUS |
Type 1 - New Molecular Entity |
Approval |
03/18/2022 |
CYLTEZO BLA #761058 |
SUPPL-11 |
ADALIMUMAB-ADBM |
BOEHRINGER INGELHEIM |
|
Approval |
03/18/2022 |
OPDUALAG BLA #761234 |
ORIG-1 |
NIVOLUMAB;RELATLIMAB-RMBW |
BRISTOL MYERS SQUIBB |
|
Approval |
03/21/2022 |
CHLOROQUINE PHOSPHATE ANDA #091621 |
SUPPL-3 |
CHLOROQUINE PHOSPHATE |
NATCO PHARMA LTD |
Labeling |
Approval |
03/21/2022 |
CHLOROQUINE PHOSPHATE ANDA #091621 |
SUPPL-4 |
CHLOROQUINE PHOSPHATE |
NATCO PHARMA LTD |
Labeling |
Approval |
03/21/2022 |
KEYTRUDA BLA #125514 |
SUPPL-110 |
PEMBROLIZUMAB |
MERCK SHARP DOHME |
|
Approval |
03/21/2022 |
JARDIANCE NDA #204629 |
SUPPL-34 |
EMPAGLIFLOZIN |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
03/21/2022 |
GLYXAMBI NDA #206073 |
SUPPL-31 |
EMPAGLIFLOZIN; LINAGLIPTIN |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
03/21/2022 |
SYNJARDY NDA #206111 |
SUPPL-31 |
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
03/21/2022 |
DABIGATRAN ETEXILATE MESYLATE ANDA #207922 |
ORIG-1 |
DABIGATRAN ETEXILATE MESYLATE |
BRECKENRIDGE PHARMS |
|
Tentative Approval |
03/21/2022 |
SYNJARDY XR NDA #208658 |
SUPPL-17 |
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
03/21/2022 |
IVERMECTIN ANDA #212485 |
ORIG-1 |
IVERMECTIN |
TEVA PHARMS USA |
|
Approval |
03/21/2022 |
LOPINAVIR AND RITONAVIR ANDA #213857 |
ORIG-1 |
LOPINAVIR; RITONAVIR |
LAURUS |
|
Approval |
03/21/2022 |
ESMOLOL HYDROCHLORIDE ANDA #216244 |
ORIG-1 |
ESMOLOL HYDROCHLORIDE |
EUGIA PHARMA |
|
Approval |
03/22/2022 |
METRONIDAZOLE ANDA #070027 |
SUPPL-47 |
METRONIDAZOLE |
TEVA PHARMS USA |
Labeling |
Approval |
03/22/2022 |
METRONIDAZOLE ANDA #070027 |
SUPPL-50 |
METRONIDAZOLE |
TEVA PHARMS USA |
Labeling |
Approval |
03/22/2022 |
METRONIDAZOLE ANDA #070033 |
SUPPL-47 |
METRONIDAZOLE |
PLIVA |
Labeling |
Approval |
03/22/2022 |
METRONIDAZOLE ANDA #070033 |
SUPPL-51 |
METRONIDAZOLE |
PLIVA |
Labeling |
Approval |
03/22/2022 |
GALANTAMINE HYDROBROMIDE ANDA #077608 |
SUPPL-6 |
GALANTAMINE HYDROBROMIDE |
HIKMA |
Labeling |
Approval |
03/22/2022 |
GALANTAMINE HYDROBROMIDE ANDA #077608 |
SUPPL-7 |
GALANTAMINE HYDROBROMIDE |
HIKMA |
Labeling |
Approval |
03/22/2022 |
CYRAMZA BLA #125477 |
SUPPL-42 |
RAMUCIRUMAB |
ELI LILLY AND CO |
|
Approval |
03/22/2022 |
SMOFLIPID 20% NDA #207648 |
SUPPL-5 |
FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL |
FRESENIUS KABI USA |
Efficacy |
Approval |
03/22/2022 |
IBUPROFEN ANDA #208865 |
SUPPL-9 |
IBUPROFEN |
AUROBINDO PHARMA |
Manufacturing (CMC) |
Approval |
03/22/2022 |
HYFTOR NDA #213478 |
ORIG-1 |
SIROLIMUS |
NOBELPHARMA |
Type 3 - New Dosage Form |
Approval |
03/22/2022 |
PREGABALIN ANDA #215249 |
ORIG-1 |
PREGABALIN |
RUBICON |
|
Approval |
03/22/2022 |
XELSTRYM NDA #215401 |
ORIG-1 |
DEXTROAMPHETAMINE |
NOVEN PHARMS INC |
Type 3 - New Dosage Form |
Approval |
03/22/2022 |
EMPLICITI BLA #761035 |
SUPPL-15 |
ELOTUZUMAB |
BRISTOL MYERS SQUIBB |
|
Approval |
03/23/2022 |
ZOSYN IN PLASTIC CONTAINER NDA #050750 |
SUPPL-48 |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
03/23/2022 |
DIAZEPAM ANDA #071309 |
SUPPL-8 |
DIAZEPAM |
HIKMA |
Labeling |
Approval |
03/23/2022 |
DIAZEPAM ANDA #071310 |
SUPPL-9 |
DIAZEPAM |
HIKMA |
Labeling |
Approval |
03/23/2022 |
DIAZEPAM ANDA #210363 |
SUPPL-7 |
DIAZEPAM |
BELOTECA |
Labeling |
Approval |
03/23/2022 |
SILDENAFIL CITRATE ANDA #211638 |
ORIG-1 |
SILDENAFIL CITRATE |
LUPIN LTD |
|
Approval |
03/23/2022 |
VOCABRIA NDA #212887 |
SUPPL-3 |
CABOTEGRAVIR SODIUM |
VIIV HLTHCARE |
Efficacy |
Approval |
03/23/2022 |
CABENUVA KIT NDA #212888 |
SUPPL-3 |
CABOTEGRAVIR; RILPIVIRINE |
VIIV HLTHCARE |
Efficacy |
Approval |
03/23/2022 |
EPLERENONE ANDA #214663 |
ORIG-1 |
EPLERENONE |
RISING |
|
Approval |
03/23/2022 |
AMINOCAPROIC ACID ANDA #215510 |
ORIG-1 |
AMINOCAPROIC ACID |
FLORIDA |
|
Approval |
03/23/2022 |
KETOROLAC TROMETHAMINE ANDA #215788 |
ORIG-1 |
KETOROLAC TROMETHAMINE |
SENORES PHARMS |
|
Approval |
03/23/2022 |
PLUVICTO NDA #215833 |
ORIG-1 |
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN |
NOVARTIS |
Type 1 - New Molecular Entity |
Approval |
03/23/2022 |
LOCAMETZ NDA #215841 |
ORIG-1 |
GALLIUM GA-68 GOZETOTIDE |
NOVARTIS |
Type 2 - New Active Ingredient |
Approval |
03/23/2022 |
LIDOCAINE HYDROCHLORIDE ANDA #216250 |
ORIG-1 |
LIDOCAINE HYDROCHLORIDE |
NOVITIUM PHARMA |
|
Approval |
03/24/2022 |
CISPLATIN NDA #018057 |
SUPPL-92 |
CISPLATIN |
HQ SPCLT PHARMA |
Labeling |
Approval |
03/24/2022 |
PLATINOL NDA #018057 |
SUPPL-92 |
CISPLATIN |
HQ SPCLT PHARMA |
Labeling |
Approval |
03/24/2022 |
PLATINOL-AQ NDA #018057 |
SUPPL-92 |
CISPLATIN |
HQ SPCLT PHARMA |
Labeling |
Approval |
03/24/2022 |
GLEEVEC NDA #021588 |
SUPPL-60 |
IMATINIB MESYLATE |
NOVARTIS |
Labeling |
Approval |
03/24/2022 |
INVEGA NDA #021999 |
SUPPL-39 |
PALIPERIDONE |
JANSSEN PHARMS |
Manufacturing (CMC) |
Approval |
03/24/2022 |
CALQUENCE NDA #210259 |
SUPPL-9 |
ACALABRUTINIB |
ASTRAZENECA |
Labeling |
Approval |
03/24/2022 |
YONSA NDA #210308 |
SUPPL-3 |
ABIRATERONE ACETATE |
SUN PHARM |
Labeling |
Approval |
03/24/2022 |
INQOVI NDA #212576 |
SUPPL-3 |
CEDAZURIDINE; DECITABINE |
OTSUKA |
Labeling |
Approval |
03/24/2022 |
POTASSIUM CHLORIDE ANDA #214108 |
ORIG-1 |
POTASSIUM CHLORIDE |
RUBICON |
|
Approval |
03/24/2022 |
CLOBAZAM ANDA #214404 |
ORIG-1 |
CLOBAZAM |
AUROBINDO PHARMA LTD |
|
Approval |
03/24/2022 |
VEKLURY NDA #214787 |
SUPPL-13 |
REMDESIVIR |
GILEAD SCIENCES INC |
Labeling |
Approval |
03/25/2022 |
CIPRO NDA #019847 |
SUPPL-63 |
CIPROFLOXACIN |
BAYER HLTHCARE |
Labeling |
Approval |
03/25/2022 |
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER NDA #019857 |
SUPPL-73 |
CIPROFLOXACIN |
BAYER HLTHCARE |
Labeling |
Approval |
03/25/2022 |
FINTEPLA NDA #212102 |
SUPPL-3 |
FENFLURAMINE HYDROCHLORIDE |
UCB INC |
Efficacy |
Approval |
03/25/2022 |
PIRFENIDONE ANDA #212570 |
ORIG-1 |
PIRFENIDONE |
AMNEAL |
|
Approval |
03/25/2022 |
PRADAXA NDA #214358 |
SUPPL-1 |
DABIGATRAN ETEXILATE MESYLATE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
03/25/2022 |
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE ANDA #215135 |
ORIG-1 |
ACETAMINOPHEN; BUTALBITAL; CAFFEINE |
HIKMA |
|
Approval |
03/27/2022 |
TYKERB NDA #022059 |
SUPPL-31 |
LAPATINIB DITOSYLATE |
NOVARTIS |
Labeling |
Approval |
03/28/2022 |
CAPRELSA NDA #022405 |
SUPPL-19 |
VANDETANIB |
GENZYME CORP |
Labeling |
Approval |
03/28/2022 |
FEBUXOSTAT ANDA #206266 |
ORIG-1 |
FEBUXOSTAT |
PRINSTON INC |
|
Approval |
03/28/2022 |
EXEMESTANE ANDA #206421 |
SUPPL-6 |
EXEMESTANE |
AMNEAL PHARMS |
Labeling |
Approval |
03/28/2022 |
TLANDO NDA #208088 |
ORIG-1 |
TESTOSTERONE UNDECANOATE |
VERITY |
Type 3 - New Dosage Form |
Approval |
03/28/2022 |
LEVETIRACETAM ANDA #209474 |
ORIG-1 |
LEVETIRACETAM |
PRINSTON INC |
|
Approval |
03/28/2022 |
OSELTAMIVIR PHOSPHATE ANDA #209590 |
ORIG-1 |
OSELTAMIVIR PHOSPHATE |
HETERO LABS LTD V |
|
Approval |
03/28/2022 |
OZEMPIC NDA #209637 |
SUPPL-9 |
SEMAGLUTIDE |
NOVO |
Efficacy |
Approval |
03/28/2022 |
ALYQ ANDA #209942 |
SUPPL-5 |
TADALAFIL |
TEVA PHARMS USA |
Labeling |
Approval |
03/28/2022 |
DEXTROSE 5% AND LACTATED RINGER'S ANDA #210332 |
ORIG-1 |
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE |
FRESENIUS KABI USA |
|
Approval |
03/28/2022 |
TOLVAPTAN ANDA #211891 |
SUPPL-1 |
TOLVAPTAN |
ALKEM LABS LTD |
Labeling |
Approval |
03/28/2022 |
XPOVIO NDA #212306 |
SUPPL-10 |
SELINEXOR |
KARYOPHARM THERAPS |
Labeling |
Approval |
03/28/2022 |
ABIRATERONE ACETATE ANDA #212462 |
SUPPL-4 |
ABIRATERONE ACETATE |
QILU |
Labeling |
Approval |
03/28/2022 |
RAMELTEON ANDA #213186 |
SUPPL-4 |
RAMELTEON |
GRANULES |
Labeling |
Approval |
03/28/2022 |
PREDNISONE ANDA #215672 |
ORIG-1 |
PREDNISONE |
AUROBINDO PHARMA LTD |
|
Approval |
03/28/2022 |
HYRIMOZ BLA #761071 |
SUPPL-11 |
ADALIMUMAB-ADAZ |
SANDOZ INC |
|
Approval |
03/29/2022 |
PLEGRIDY BLA #125499 |
SUPPL-25 |
PEGINTERFERON BETA-1A |
BIOGEN IDEC INC |
|
Approval |
03/29/2022 |
EDURANT NDA #202022 |
SUPPL-17 |
RILPIVIRINE HYDROCHLORIDE |
JANSSEN PRODS |
Efficacy |
Approval |
03/29/2022 |
EDURANT NDA #202022 |
SUPPL-18 |
RILPIVIRINE HYDROCHLORIDE |
JANSSEN PRODS |
Efficacy |
Approval |
03/29/2022 |
VOCABRIA NDA #212887 |
SUPPL-5 |
CABOTEGRAVIR SODIUM |
VIIV HLTHCARE |
Efficacy |
Approval |
03/29/2022 |
VOCABRIA NDA #212887 |
SUPPL-6 |
CABOTEGRAVIR SODIUM |
VIIV HLTHCARE |
Efficacy |
Approval |
03/29/2022 |
CABENUVA KIT NDA #212888 |
SUPPL-5 |
CABOTEGRAVIR; RILPIVIRINE |
VIIV HLTHCARE |
Efficacy |
Approval |
03/29/2022 |
CABENUVA KIT NDA #212888 |
SUPPL-6 |
CABOTEGRAVIR; RILPIVIRINE |
VIIV HLTHCARE |
Efficacy |
Approval |
03/29/2022 |
BRIVARACETAM ANDA #214880 |
ORIG-1 |
BRIVARACETAM |
MICRO LABS |
|
Tentative Approval |
03/29/2022 |
NIFEDIPINE ANDA #216067 |
ORIG-1 |
NIFEDIPINE |
ALKEM LABS LTD |
|
Approval |
03/29/2022 |
FLUOXETINE HYDROCHLORIDE ANDA #216232 |
ORIG-1 |
FLUOXETINE HYDROCHLORIDE |
MICRO LABS |
|
Approval |
03/30/2022 |
FUROSEMIDE NDA #018579 |
SUPPL-33 |
FUROSEMIDE |
AM REGENT |
Manufacturing (CMC) |
Approval |
03/30/2022 |
TRIUMEQ NDA #205551 |
SUPPL-28 |
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE |
VIIV HLTHCARE |
Efficacy |
Approval |
03/30/2022 |
TISSUEBLUE NDA #209569 |
SUPPL-4 |
BRILLIANT BLUE G |
DUTCH OPHTHALMIC |
Labeling |
Approval |
03/30/2022 |
SODIUM PHOSPHATES ANDA #209997 |
ORIG-1 |
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS |
FRESENIUS KABI USA |
|
Approval |
03/30/2022 |
RIOCIGUAT ANDA #211044 |
ORIG-1 |
RIOCIGUAT |
TEVA PHARMS USA INC |
|
Tentative Approval |
03/30/2022 |
DOXYCYCLINE HYCLATE ANDA #212487 |
ORIG-1 |
DOXYCYCLINE HYCLATE |
PRAXGEN |
|
Approval |
03/30/2022 |
DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE NDA #212527 |
ORIG-1 |
DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE |
CIPLA USA INC. |
Type 4 - New Combination |
Tentative Approval |
03/30/2022 |
ENALAPRIL MALEATE ANDA #213714 |
ORIG-1 |
ENALAPRIL MALEATE |
ALKEM LABS LTD |
|
Approval |
03/30/2022 |
IOFLUPANE I-123 ANDA #213792 |
ORIG-1 |
IOFLUPANE I-123 |
CURIUM |
|
Approval |
03/30/2022 |
IBUPROFEN ANDA #215318 |
ORIG-1 |
IBUPROFEN |
YICHANG HUMANWELL |
|
Approval |
03/30/2022 |
TRIUMEQ PD NDA #215413 |
ORIG-1 |
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE |
VIIV HLTHCARE |
Type 3 - New Dosage Form |
Approval |
03/30/2022 |
POTELIGEO BLA #761051 |
SUPPL-15 |
MOGAMULIZUMAB-KPKC |
KYOWA KIRIN |
|
Approval |
03/31/2022 |
PROMACTA NDA #022291 |
SUPPL-33 |
ELTROMBOPAG OLAMINE |
NOVARTIS |
Labeling |
Approval |
03/31/2022 |
DIPYRIDAMOLE ANDA #040782 |
SUPPL-14 |
DIPYRIDAMOLE |
IMPAX LABS |
Labeling |
Approval |
03/31/2022 |
METRONIDAZOLE ANDA #070039 |
SUPPL-15 |
METRONIDAZOLE |
STRIDES PHARMA |
Labeling |
Approval |
03/31/2022 |
METRONIDAZOLE ANDA #070040 |
SUPPL-15 |
METRONIDAZOLE |
STRIDES PHARMA |
Labeling |
Approval |
03/31/2022 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM ANDA #071017 |
SUPPL-70 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
03/31/2022 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM ANDA #071017 |
SUPPL-72 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
03/31/2022 |
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE ANDA #075579 |
SUPPL-25 |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
EPIC PHARMA LLC |
Labeling |
Approval |
03/31/2022 |
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE ANDA #075579 |
SUPPL-27 |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
EPIC PHARMA LLC |
Labeling |
Approval |
03/31/2022 |
PAROXETINE HYDROCHLORIDE ANDA #077395 |
SUPPL-14 |
PAROXETINE HYDROCHLORIDE |
APOTEX INC |
Labeling |
Approval |
03/31/2022 |
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE ANDA #090894 |
SUPPL-6 |
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
TEVA PHARMS USA |
Labeling |
Approval |
03/31/2022 |
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE ANDA #090894 |
SUPPL-8 |
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
TEVA PHARMS USA |
Labeling |
Approval |
03/31/2022 |
QUINAPRIL HYDROCHLORIDE ANDA #202725 |
SUPPL-13 |
QUINAPRIL HYDROCHLORIDE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
03/31/2022 |
METRONIDAZOLE ANDA #203458 |
SUPPL-14 |
METRONIDAZOLE |
UNICHEM |
Labeling |
Approval |
03/31/2022 |
JUBLIA NDA #203567 |
SUPPL-10 |
EFINACONAZOLE |
BAUSCH |
Labeling |
Approval |
03/31/2022 |
METRONIDAZOLE ANDA #203974 |
SUPPL-10 |
METRONIDAZOLE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
03/31/2022 |
CLOPIDOGREL BISULFATE ANDA #204165 |
SUPPL-18 |
CLOPIDOGREL BISULFATE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
03/31/2022 |
GABAPENTIN ANDA #206402 |
SUPPL-20 |
GABAPENTIN |
ALKEM LABS LTD |
Labeling |
Approval |
03/31/2022 |
PROMACTA KIT NDA #207027 |
SUPPL-15 |
ELTROMBOPAG OLAMINE |
NOVARTIS |
Labeling |
Approval |
03/31/2022 |
OXALIPLATIN ANDA #207562 |
SUPPL-6 |
OXALIPLATIN |
NOVAST LABS |
Labeling |
Approval |
03/31/2022 |
WIXELA INHUB ANDA #208891 |
SUPPL-9 |
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE |
MYLAN |
Labeling |
Approval |
03/31/2022 |
METRONIDAZOLE ANDA #209096 |
SUPPL-3 |
METRONIDAZOLE |
LUPIN LTD |
Labeling |
Approval |
03/31/2022 |
DAPSONE ANDA #210178 |
ORIG-1 |
DAPSONE |
COSETTE |
|
Approval |
03/31/2022 |
POTASSIUM CHLORIDE ANDA #211067 |
SUPPL-2 |
POTASSIUM CHLORIDE |
APOTEX |
Labeling |
Approval |
03/31/2022 |
TEGSEDI NDA #211172 |
SUPPL-11 |
INOTERSEN SODIUM |
AKCEA THERAPS |
REMS |
Approval |
03/31/2022 |
SUCCINYLCHOLINE CHLORIDE ANDA #212638 |
SUPPL-2 |
SUCCINYLCHOLINE CHLORIDE |
BRECKENRIDGE |
Labeling |
Approval |
03/31/2022 |
NURTEC ODT NDA #212728 |
SUPPL-14 |
RIMEGEPANT SULFATE |
PFIZER |
Manufacturing (CMC) |
Approval |
03/31/2022 |
EPHEDRINE SULFATE ANDA #212932 |
SUPPL-1 |
EPHEDRINE SULFATE |
AMNEAL |
Labeling |
Approval |
03/31/2022 |
EPHEDRINE SULFATE ANDA #212932 |
SUPPL-2 |
EPHEDRINE SULFATE |
AMNEAL |
Labeling |
Approval |
03/31/2022 |
NEBIVOLOL HYDROCHLORIDE ANDA #213349 |
ORIG-1 |
NEBIVOLOL HYDROCHLORIDE |
AJANTA PHARMA LTD |
|
Approval |
03/31/2022 |
POTASSIUM CITRATE ANDA #214420 |
SUPPL-1 |
POTASSIUM CITRATE |
ASCENT PHARMS INC |
Labeling |
Approval |
03/31/2022 |
POTASSIUM CITRATE ANDA #214426 |
SUPPL-4 |
POTASSIUM CITRATE |
EYWA |
Labeling |
Approval |
03/31/2022 |
EPHEDRINE SULFATE ANDA #214579 |
SUPPL-1 |
EPHEDRINE SULFATE |
EUGIA PHARMA |
Labeling |
Approval |
03/31/2022 |
LACOSAMIDE ANDA #214695 |
ORIG-1 |
LACOSAMIDE |
ALKEM LABS LTD |
|
Approval |
03/31/2022 |
SUCCINYLCHOLINE CHLORIDE ANDA #214879 |
SUPPL-4 |
SUCCINYLCHOLINE CHLORIDE |
MICRO LABS |
Labeling |
Approval |
03/31/2022 |
SUCCINYLCHOLINE CHLORIDE ANDA #214879 |
SUPPL-5 |
SUCCINYLCHOLINE CHLORIDE |
MICRO LABS |
Labeling |
Approval |
03/31/2022 |
CARBAMAZEPINE ANDA #215591 |
ORIG-1 |
CARBAMAZEPINE |
ZHEJIANG JIUZHOU |
|
Approval |
03/31/2022 |
ACYCLOVIR ANDA #216331 |
ORIG-1 |
ACYCLOVIR |
AUROBINDO PHARMA |
|
Approval |